NS Partners International Equity (S:0P00003I3O)
546.42
-3.58
(-0.65%)
USD |
Nov 30 2025
Returns Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Key Stats
Basic Info
| Investment Strategy | |
| None |
| General | |
| Security Type | None |
| Equity Style | None |
| Fixed Income Style | None |
| Broad Asset Class | None |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Fund Owner Firm Name | None |
| Broad Asset Class Benchmark Index | |
| None | |
Annual Total Returns Versus Peers
As of December 24, 2025.
Asset Allocation
| Type | % Net |
|---|---|
| Cash | -- |
| Stock | -- |
| Bond | -- |
| Convertible | -- |
| Preferred | -- |
| Other | -- |
Top 10 Holdings
| Name | % Weight | Price | % Change |
|---|---|---|---|
| AstraZeneca PLC | 3.58% | 183.00 | 1.24% |
| SSE Plc | 2.93% | 28.42 | 0.00% |
| Roche Holding AG | 2.89% | 407.99 | -2.69% |
| Mitsubishi UFJ Financial Group, Inc. | 2.69% | 16.31 | 0.99% |
| Rio Tinto Ltd. | 2.68% | 94.69 | 0.00% |
| CaixaBank SA | 2.46% | 11.96 | 0.00% |
| SAP SE | 2.42% | 246.53 | 0.36% |
| KBC Group NV | 2.40% | 119.42 | 0.00% |
| Schneider Electric SE | 2.20% | 288.00 | 4.20% |
| Sony Group Corp. | 2.16% | 26.78 | 3.41% |
Fees & Availability
| Fees | |
| Negotiable Fee | -- |
| Maximum Management Fee | -- |
| Prospectus Custodian Fee | -- |
| Purchase Details | |
| Open to New Investors | -- |
Basic Info
| Investment Strategy | |
| None |
| General | |
| Security Type | None |
| Equity Style | None |
| Fixed Income Style | None |
| Broad Asset Class | None |
| YCharts Categorization | -- |
| YCharts Benchmark | -- |
| Fund Owner Firm Name | None |
| Broad Asset Class Benchmark Index | |
| None | |
Fundamentals
| General | |
| Number of Holdings | -- |
| Stock | |
| Weighted Average PE Ratio | -- |
| Weighted Average Price to Sales Ratio | -- |
| Weighted Average Price to Book Ratio | -- |
| Weighted Median ROE | -- |
| Weighted Median ROA | -- |
| Number of Equity Holdings | -- |
Fund Details
| Key Dates | |
| Inception Date | -- |
| Attributes | |
| Socially Responsible Fund | -- |